Clinical and Functional Outcome of the MobileLink Acetabular Cup System in the Short-, Mid-, and Longterm Follow-up
NCT04688593
Summary
The implantation of artificial hip joints is one of the most frequently performed surgeries. Normally, patients are very satisfied with the results. The MobileLink hip prosthesis system is a CE marked medical device. This means the the safety and performance of the prosthesis ist approved. Aim of the study is to collect clinical data about the outcome of the MobileLink hip prosthesis system under routine condition and to determine the satisfaction of the patients.
Eligibility
Inclusion Criteria: * Implantation of a MobileLink acetabular cup system and a femoral stem manufactured by Waldemar Link * Age ≥ 18 years * Fully signed patient informed cons Exclusion Criteria: * Revisions * Body Mass Index (BMI) ≥ 40 kg/m² * Patient who is foreseeable not able to understand the study and the study-related circumstances * Patients who is foreseeable non-compliant to the treatment and the follow-ups * Pregnant or breast-feeding women * Prisoner
Conditions5
Browse More Trials
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.
NCT04688593